A pilot study to investigate whether fatigue is a side effect of etanercept in patients with moderate to severe psoriasis

Phase 4

• Conditions: psoriasis; 10040785

• Registration Number: NL-OMON29881
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 160

Inclusion Criteria

- Adult patients at the outpatient clinic diagnosed psoriasis with a PASI score *10
- Patients selected for treatment with etanercept
- Patients selected for treatment with narrowband UVB therapy

Exclusion Criteria

- PASI<10
- unable to complete the questionnaires
- uncontrolled co-morbidity known to cause fatigue
- concomitant medication known to have fatigue as aside effect

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The percentage of patients on etanercept therapy who report fatigue, as<br /><br>identified by three validated questionnaires, compared to a similar group of<br /><br>psoriasis patients receiving phototherapy. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>